These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 14561478)
1. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Zarranz B; Jaso A; Aldana I; Monge A Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents. Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298 [TBL] [Abstract][Full Text] [Related]
6. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide. Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199 [TBL] [Abstract][Full Text] [Related]
7. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660 [TBL] [Abstract][Full Text] [Related]
8. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970 [TBL] [Abstract][Full Text] [Related]
12. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis. Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold. Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048 [TBL] [Abstract][Full Text] [Related]
14. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives. Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528 [TBL] [Abstract][Full Text] [Related]
15. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones. Ramalingam P; Ganapaty S; Rao ChB Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity. Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives. Puratchikody A; Natarajan R; Jayapal M; Doble M Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides. Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis. Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]